Hauke Felix Wiegand1, Joachim Saam2, Ursula Marschall2, Andrea Chmitorz3, Levente Kriston4, Mathias Berger5, Klaus Lieb1, Lars P Hölzel6. 1. Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Mainz, Germany. 2. Department of Medicine and Health Services Research, BARMER Statutory Health Insurance Fund, Wuppertal, Germany. 3. Faculty of Social Work, Health and Nursing Sciences, Esslingen University of Applied Sciences, Esslingen, Germany. 4. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 5. Department of Psychiatry and Psychotherapy, University Hospital Freiburg, Freiburg, Germany. 6. Oberberg Parkklinik Wiesbaden Schlangenbad, Wiesbaden, Germany.
Abstract
BACKGROUND: Few data are available on the characteristics of inpatient treatment and subsequent outpatient treatment for depression in Germany. In this study, we aimed to characterize the inpatient and outpatient treatment phases, to determine the rates of readmission and mortality, and to identify risk factors. METHODS: We carried out a descriptive statistical analysis of routine administrative data from a large health-insurance carrier (BARMER). All insurees aged 18 to 65 who were treated in 2015 as inpatients on a psychiatry and psychotherapy service or on a psychosomatic medicine and psychotherapy service with a main diagnosis of depression were included in the analysis. Risk factors for readmission and death were determined with the aid of mixed logistic regression. RESULTS: Of the 22 893 patients whose data were analyzed, 78% had been hospitalized on a psychiatry and psychotherapy service and 22% on a psychosomatic medicine and psychotherapy service. The median length of hospital stay was 42 days. Follow-up care in the outpatient setting failed to conform with the recommendations of the pertinent guidelines in 92% of the patients with a main diagnosis of severe depression during hospitalization, and in 50% of those with moderate depression. 21% of the patients were readmitted within a year. The mortality at one year was 961 per 100 000 individuals (adjusted for the age and sex structure of the German population), or 3.4 times the mortality of the population at large. In the regression model, more treatment units during hospitalization and subsequent treatment with psychotherapy were associated with a lower probability of readmission, while longer hospitalization with subsequent pharmacotherapy or psychotherapy was associated with lower mortality. CONCLUSION: The recommendations of the national (German) S3 guidelines for the further care of patients who have been hospitalized for depression are inadequately implemented at present in the sectored structures of in- and outpatient care in the German health care system. This patient group has marked excess mortality.
BACKGROUND: Few data are available on the characteristics of inpatient treatment and subsequent outpatient treatment for depression in Germany. In this study, we aimed to characterize the inpatient and outpatient treatment phases, to determine the rates of readmission and mortality, and to identify risk factors. METHODS: We carried out a descriptive statistical analysis of routine administrative data from a large health-insurance carrier (BARMER). All insurees aged 18 to 65 who were treated in 2015 as inpatients on a psychiatry and psychotherapy service or on a psychosomatic medicine and psychotherapy service with a main diagnosis of depression were included in the analysis. Risk factors for readmission and death were determined with the aid of mixed logistic regression. RESULTS: Of the 22 893 patients whose data were analyzed, 78% had been hospitalized on a psychiatry and psychotherapy service and 22% on a psychosomatic medicine and psychotherapy service. The median length of hospital stay was 42 days. Follow-up care in the outpatient setting failed to conform with the recommendations of the pertinent guidelines in 92% of the patients with a main diagnosis of severe depression during hospitalization, and in 50% of those with moderate depression. 21% of the patients were readmitted within a year. The mortality at one year was 961 per 100 000 individuals (adjusted for the age and sex structure of the German population), or 3.4 times the mortality of the population at large. In the regression model, more treatment units during hospitalization and subsequent treatment with psychotherapy were associated with a lower probability of readmission, while longer hospitalization with subsequent pharmacotherapy or psychotherapy was associated with lower mortality. CONCLUSION: The recommendations of the national (German) S3 guidelines for the further care of patients who have been hospitalized for depression are inadequately implemented at present in the sectored structures of in- and outpatient care in the German health care system. This patient group has marked excess mortality.
Authors: C Normann; J Wolff; A Hochlehnert; J P Klein; F Hohagen; K Lieb; J Deckert; P Falkai; M Berger; S C Herpertz Journal: Nervenarzt Date: 2015-05 Impact factor: 1.214
Authors: David P Herzog; Stefanie Wagner; Christian Ruckes; André Tadic; Sibylle C Roll; Martin Härter; Klaus Lieb Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-04-18 Impact factor: 5.270
Authors: Isaac Bermejo; Lars P Hölzel; Ulrich Voderholzer; Ludger Tebartz van Elst; Mathias Berger Journal: Z Evid Fortbild Qual Gesundhwes Date: 2012-06-20
Authors: Jose M Rubio; Mark Olfson; Gabriela Pérez-Fuentes; Mauro Garcia-Toro; Shuai Wang; Carlos Blanco Journal: J Nerv Ment Dis Date: 2014-04 Impact factor: 2.254
Authors: K Mikael Holma; Irina A K Holma; Tarja K Melartin; Heikki J Rytsälä; Erkki T Isometsä Journal: J Clin Psychiatry Date: 2008-02 Impact factor: 4.384
Authors: Hauke Felix Wiegand; Anna-Lena Bröcker; Mandy Fehr; Niklas Lohmann; Birgit Maicher; Nikolaus Röthke; Mike Rueb; Paula Wessels; Moritz de Greck; Andrea Pfennig; Stefan Unterecker; Oliver Tüscher; Henrik Walter; Peter Falkai; Klaus Lieb; Lars Peer Hölzel; Kristina Adorjan Journal: Front Psychiatry Date: 2022-04-27 Impact factor: 5.435